Blackstone Group »

Fulcrum Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $130k 19k 6.75
2023-09-30 $85k 19k 4.44
2023-06-30 $63k 19k 3.30
2023-03-31 $55k 19k 2.85
2022-12-31 $140k 19k 7.28
2022-03-31 $225k 9.5k 23.68
2021-09-30 $134k 4.8k 28.16